Outcome of Board Meeting - Forty Second Annual General Meeting of the Company on 7th August, 2026
CHEMPLASTS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.5 pts less than Nifty Microcap 250 and 5.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chemplast Sanmar reported FY 2025-26 annual results with standalone revenue declining 9.1% to ₹2,170 crores and consolidated revenue declining 2.8% to ₹4,224 crores compared to the previous year. The company recorded a massive exceptional item of ₹898 crores as impairment provision for its wholly owned subsidiary CCVL (engaged in Suspension PVC business), citing regulatory changes including dropping of expected anti-dumping duty, removal of customs duty on S-PVC imports, and significant price reduction due to low-cost imports and raw material volatility from the West Asia crisis. Standalone loss before tax was ₹1,039 crores and consolidated loss before tax was ₹372 crores. The Board has not recommended any dividend for FY 2025-26. Statutory auditors BSR & Co LLP issued unmodified opinion on both standalone and consolidated financials.
The significant revenue decline and massive exceptional impairment charge reflect serious challenges in the company's PVC subsidiary business due to unfavourable regulatory and market conditions. The stock may face negative sentiment in the near term due to losses and no dividend, though the formation of an Independent Directors committee to explore strategic options and M&A could signal potential restructuring ahead.